John L. LaMattina, Ph.D.

John L. LaMattina, Ph.D.

DirectoratLigand Pharmaceuticals· In proxies 2023–2025

John L. LaMattina, Ph.D. sits on 1 public board.

Experience

  1. Ligand PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +387%
  2. PureTech Health Former President for Pfizer Global R&DPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?